Dr. Mazen Hanna describes the findings of ATTR-ACT, a study aimed at the treatment of transthyretin (TTR) amyloid cardiomyopathy with the medication tafamadis. Those who were treated with the…
Cardiac Amyloidosis Dr. Mazen Hanna, co-director of Cleveland Clinic’s Amyloidosis Center leads this deep dive view of cardiac amyloidosis. Following a case study, experts provide insight into…